Newbridge Financial Services Group, Inc. Caribou Biosciences, Inc. Transaction History
Newbridge Financial Services Group, Inc.
- $391 Million
- Q1 2025
A detailed history of Newbridge Financial Services Group, Inc. transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Newbridge Financial Services Group, Inc. holds 2,000 shares of CRBU stock, worth $2,400. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,000
Previous 2,000
-0.0%
Holding current value
$2,400
Previous $3,000
66.67%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CRBU
# of Institutions
136Shares Held
47.1MCall Options Held
17.1KPut Options Held
58.1K-
Black Rock Inc. New York, NY6.95MShares$8.34 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.52MShares$5.43 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.27MShares$3.92 Million0.25% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA2.51MShares$3.01 Million0.18% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY2.35MShares$2.82 Million0.01% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $73M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...